Trial
NCT06695507
Upfront Ruxolitinib for Chronic Graft-vs-host Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
—
Condition
Chronic Graft Versus Host Disease
Intervention
Ruxolitinib
Why stopped
Study closed due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-25